Table 3

Pathological characteristics of patients with COVID-19

CharacteristicNo. of studiesNo. of patientsHeterogeneityModelMeta-analysis
P valueI2 (%)R (95% CI)P value
Leucocytosis213936<0.00190.6Random0.099 (0.069 to 0.134)<0.001
Normal leucocyte count233267<0.00189.5Random0.647 (0.591 to 0.700)<0.001
Leucopenia274233<0.00189.6Random0.235 (0.194 to 0.279)<0.001
Lymphopaenia324660<0.00194.4Random0.476 (0.413 to 0.540)<0.001
High C reactive protein232912<0.00193.2Random0.659 (0.586 to 0.728)<0.001
High procalcitonin132190<0.00196.6Random0.167 (0.083 to 0.274)<0.001
High D-dimer92354<0.00190.4Random0.204 (0.147 to 0.267)<0.001
High erythrocyte sedimentation rate7455<0.00190.4Random0.204 (0.147 to 0.267)<0.001
Abnormal liver function112524<0.00190.1Random0.264 (0.204 to 0.329)<0.001
Abnormal renal function82183<0.00196.1Random0.109 (0.045 to 0.196)<0.001
High myocardial enzymes112541<0.00196.1Random0.494 (0.264 to 0.725)<0.001